259 related articles for article (PubMed ID: 20335656)
1. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.
Kelishadi SS; Azimzadeh AM; Zhang T; Stoddard T; Welty E; Avon C; Higuchi M; Laaris A; Cheng XF; McMahon C; Pierson RN
J Clin Invest; 2010 Apr; 120(4):1275-84. PubMed ID: 20335656
[TBL] [Abstract][Full Text] [Related]
2. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
[TBL] [Abstract][Full Text] [Related]
3. Prevention trumps treatment of antibody-mediated transplant rejection.
Knechtle SJ; Kwun J; Iwakoshi N
J Clin Invest; 2010 Apr; 120(4):1036-9. PubMed ID: 20335653
[TBL] [Abstract][Full Text] [Related]
4. B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation.
Marino J; Paster JT; Trowell A; Maxwell L; Briggs KH; Crosby Bertorini P; Benichou G
Am J Transplant; 2016 Feb; 16(2):672-8. PubMed ID: 26552037
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys.
Schröder C; Azimzadeh AM; Wu G; Price JO; Atkinson JB; Pierson RN
Transpl Immunol; 2003; 12(1):19-28. PubMed ID: 14551029
[TBL] [Abstract][Full Text] [Related]
6. Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.
Laws LH; Parker CE; Cherala G; Koguchi Y; Waisman A; Slifka MK; Oberbarnscheidt MH; Obhrai JS; Yeung MY; Riella LV
Am J Transplant; 2016 Nov; 16(11):3139-3149. PubMed ID: 27265023
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
Simonson MS; Robinson AV; Schulak JA; Hricik DE
Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
[TBL] [Abstract][Full Text] [Related]
8. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody.
Alwayn IP; Xu Y; Basker M; Wu C; Buhler L; Lambrigts D; Treter S; Harper D; Kitamura H; Vitetta ES; Abraham S; Awwad M; White-Scharf ME; Sachs DH; Thall A; Cooper DK
Xenotransplantation; 2001 Aug; 8(3):157-71. PubMed ID: 11472623
[TBL] [Abstract][Full Text] [Related]
9. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
[TBL] [Abstract][Full Text] [Related]
10. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
[TBL] [Abstract][Full Text] [Related]
11. Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
OʼNeill NA; Zhang T; Braileanu G; Sun W; Cheng X; Hershfeld A; Laird CT; Kronfli A; Hock LA; Dahi S; Kubicki N; Sievert E; Hassanein W; Cimeno A; Pierson RN; Azimzadeh AM
Transplantation; 2017 Sep; 101(9):2038-2047. PubMed ID: 28557955
[TBL] [Abstract][Full Text] [Related]
12. B cell monitoring of transplant patients treated with anti-CD20.
Abdallah KO; Prak ET
Clin Transpl; 2006; ():427-37. PubMed ID: 18365400
[TBL] [Abstract][Full Text] [Related]
13. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
Zarkhin V; Li L; Kambham N; Sigdel T; Salvatierra O; Sarwal MM
Am J Transplant; 2008 Dec; 8(12):2607-17. PubMed ID: 18808404
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
15. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion.
Kayler LK; Lakkis FG; Morgan C; Basu A; Blisard D; Tan HP; McCauley J; Wu C; Shapiro R; Randhawa PS
Am J Transplant; 2007 Apr; 7(4):949-54. PubMed ID: 17331114
[TBL] [Abstract][Full Text] [Related]
16. Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates.
Azimzadeh AM; Pfeiffer S; Wu GS; Schröder C; Zhou H; Zorn GL; Kehry M; Miller GG; Rose ML; Pierson RN
Am J Transplant; 2005 Oct; 5(10):2349-59. PubMed ID: 16162182
[TBL] [Abstract][Full Text] [Related]
17. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.
Lehnhardt A; Mengel M; Pape L; Ehrich JH; Offner G; Strehlau J
Am J Transplant; 2006 Apr; 6(4):847-51. PubMed ID: 16539643
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
[TBL] [Abstract][Full Text] [Related]
19. Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys.
Nickerson-Nutter C; Tchistiakova L; Seth NP; Kasaian M; Sibley B; Olland S; Zollner R; Brady WA; Mohler KM; Baum P; Wahl A; Herber D; Vugmeyster Y; Wensel D; Wolfman NM; Gill D; Collins M; Dunussi-Joannopoulos K
Rheumatology (Oxford); 2011 Jun; 50(6):1033-44. PubMed ID: 21258049
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
